Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 6
Submit an article Journal homepage
475
Views
2
CrossRef citations to date
0
Altmetric
Original Article: Clinical

The impact of Agent Orange exposure on prognosis and management in patients with chronic lymphocytic leukemia: a National Veteran Affairs Tumor Registry Study

Craig MescherDivision of Hematology, Oncology and Transplant, University of Minnesota, Minneapolis, MN, USA; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-9478-6926
ORCID Icon,
David GilbertsonChronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN, USA;
,
Nicole M. RandallIndiana Hemophilia & Thrombosis Center, Indianapolis, IN, USA;
,
Gobind TarchandVeterans Affairs Medical Center, Minneapolis, MN, USA;
,
Julie TomaskaVeterans Affairs Medical Center, Minneapolis, MN, USA;
,
Lisa Baumann KreuzigerBlood Center of Wisconsin, Milwaukee, WI, USA; ;Department of Medicine, Division of Hematology, Medical College of Wisconsin, Minneapolis, MN, USA;
&
Vicki A. MorrisonHematology/Oncology & Infectious Disease, University of Minnesota, Minneapolis, MN, USA; ;Hennepin County Medical Center, Minneapolis, MN, USA
 show all
Pages 1348-1355 | Received 15 Apr 2017, Accepted 23 Aug 2017, Published online: 14 Sep 2017

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Christopher R. Frei, Hannah Le, Daniel McHugh, Kellie Ryan, Xavier Jones, Samantha Galley, Kathleen Franklin, Courtney J. Baus, Juan Tavera, Michelle Janania-Martinez, David Gregorio, Snegha Ananth, Ricardo Uribe, Prathibha Surapaneni, Manuel Espinoza-Gutarra, Michael M. Song, Chengwen Teng, Obiageri O. Obodozie-Ofoegbu & Zohra Nooruddin. (2021) Outcomes in chronic lymphocytic leukemia patients on novel agents in the US Veterans Health Administration System. Leukemia & Lymphoma 62:7, pages 1664-1673.
Read now
Laura S. Samples & Solomon A. Graf. (2018) On the front line: first choice pharmacotherapeutics for chronic lymphocytic leukemia. Expert Opinion on Pharmacotherapy 19:15, pages 1675-1684.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.